Loss per share (Tables) - CubeBio Co., Ltd. [Member]
|
6 Months Ended |
12 Months Ended |
Jun. 30, 2026 |
Dec. 31, 2025 |
| Entity Information [Line Items] |
|
|
| Schedule of loss attributable to ordinary shareholders |
| Schedule of loss attributable to ordinary shareholders |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
Six-month
period ended
June 30,
2026 |
|
|
Six-month
period ended
June 30,
2025 |
|
| |
|
|
|
(In thousands of Korean Won) |
|
| Loss for the period |
|
₩ |
|
|
(2,997,895 |
) |
|
|
(3,400,181 |
) |
| Loss attributable to ordinary shareholders |
|
₩ |
|
|
(2,997,895 |
) |
|
|
(3,400,181 |
) |
|
| Schedule of Loss attributable to ordinary shareholders (basic) |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
2025 |
|
|
2024 |
|
| |
|
|
|
(In thousands of Korean won) |
|
| Loss for the year |
|
₩ |
|
|
(6,141,476 |
) |
|
|
(8,065,334 |
) |
| Loss attributable to ordinary shareholders |
|
₩ |
|
|
(6,141,476 |
) |
|
|
(8,065,334 |
) |
|
| Schedule of weighted-average number of ordinary shares |
| Schedule of weighted-average number of ordinary shares |
|
|
|
|
|
|
|
|
| |
|
Six-month
period ended
June 30,
2026 |
|
|
Six-month
period ended
June 30,
2025 |
|
| |
|
(In number of shares) |
|
| Number of ordinary shares issued at January 1 |
|
|
48,982,075 |
|
|
|
48,361,075 |
|
| Disposal of treasury shares |
|
|
1,326 |
|
|
|
2,762 |
|
| Weighted-average number of ordinary shares at June 30 |
|
|
48,983,401 |
|
|
|
48,363,837 |
|
|
| Schedule of Weighted-average number of ordinary shares (basic) |
|
|
|
|
|
|
|
|
| |
|
2025 |
|
|
2024 |
|
| |
|
(In number of shares) |
|
| Number of ordinary shares issued at January 1 |
|
|
48,361,075 |
|
|
|
42,716,210 |
|
| Share options exercised |
|
|
- |
|
|
|
1,324,220 |
|
| Bond with warrants exercised |
|
|
217,441 |
|
|
|
734,268 |
|
| Acquisition of treasury shares |
|
|
52,055 |
|
|
|
450,821 |
|
| Weighted-average number of ordinary shares at December 31 |
|
|
48,630,571 |
|
|
|
45,225,519 |
|
|
| Schedule of anti-dilutive shares |
|
| Schedule of anti-dilutive shares |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
2025 |
|
|
2024 |
|
| |
|
|
|
(In Korean won and number of shares) |
|
| Share option |
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
₩ |
|
|
500 |
|
|
|
500 |
|
| Potential ordinary share |
|
|
|
|
640,160 |
|
|
|
640,160 |
|
| Bonds with Warrants |
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
₩ |
|
|
3,000 ~ 4,000 |
|
|
|
2,500 ~ 4,000 |
|
| Potential ordinary share (*) |
|
|
|
|
13,480,002 |
|
|
|
11,757,336 |
|
| (*) |
As of December 31, 2025, the exercise period for 1,000,000 shares of the 21st series bonds with warrants had not yet commenced. |
|
| Schedule of losses per share |
| Schedule of losses per share |
|
|
|
|
|
|
|
|
| |
|
|
|
Six-month
period ended
June 30,
2026 |
|
|
Six-month
period ended
June 30,
2025 |
|
| |
|
|
|
(In Korean Won) |
|
| Basic losses per share |
|
₩ |
|
|
(61 |
) |
|
|
(70 |
) |
|
| Schedule of losses per share |
|
|
|
|
|
|
|
|
| |
|
|
|
2025 |
|
|
2024 |
|
| |
|
|
|
(In Korean won) |
|
| Basic losses per share |
|
₩ |
|
|
(126 |
) |
|
|
(178 |
) |
|
| Schedule of potential ordinary shares |
| Schedule
of potential ordinary shares |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
Six-month
period ended
June 30,
2026 |
|
|
Six-month
period ended
June 30,
2025 |
|
| |
|
|
|
(In Korean won and number of shares) |
|
| Stock option |
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
₩ |
|
|
500 |
|
|
|
500 |
|
| Potential ordinary share |
|
|
|
|
640,160 |
|
|
|
640,160 |
|
| Bonds with Warrants |
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
₩ |
|
|
2,500 ~ 4,000 |
|
|
|
2,500 ~ 4,000 |
|
| Potential ordinary share |
|
|
|
|
13,480,002 |
|
|
|
11,903,002 |
|
|
|